LEPU ScienTech Medical Technology (Shanghai) Past Earnings Performance
Past criteria checks 5/6
LEPU ScienTech Medical Technology (Shanghai) has been growing earnings at an average annual rate of 35.6%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 41.3% per year. LEPU ScienTech Medical Technology (Shanghai)'s return on equity is 11.5%, and it has net margins of 52.9%.
Key information
35.6%
Earnings growth rate
29.0%
EPS growth rate
Medical Equipment Industry Growth | 13.7% |
Revenue growth rate | 41.3% |
Return on equity | 11.5% |
Net Margin | 52.9% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How LEPU ScienTech Medical Technology (Shanghai) makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 409 | 216 | 103 | 56 |
31 Mar 24 | 367 | 184 | 95 | 59 |
31 Dec 23 | 326 | 152 | 87 | 62 |
30 Sep 23 | 308 | 91 | 83 | 62 |
30 Jun 23 | 289 | 32 | 82 | 62 |
31 Mar 23 | 268 | 6 | 80 | 58 |
31 Dec 22 | 248 | -20 | 78 | 54 |
30 Sep 22 | 242 | 11 | 81 | 49 |
30 Jun 22 | 236 | 41 | 85 | 45 |
31 Mar 22 | 230 | 50 | 78 | 43 |
31 Dec 21 | 223 | 59 | 71 | 41 |
31 Dec 20 | 148 | 69 | 28 | 39 |
31 Dec 19 | 116 | 52 | 30 | 26 |
Quality Earnings: 2291 has high quality earnings.
Growing Profit Margin: 2291's current net profit margins (52.9%) are higher than last year (10.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2291's earnings have grown significantly by 35.6% per year over the past 5 years.
Accelerating Growth: 2291's earnings growth over the past year (586.2%) exceeds its 5-year average (35.6% per year).
Earnings vs Industry: 2291 earnings growth over the past year (586.2%) exceeded the Medical Equipment industry -4.3%.
Return on Equity
High ROE: 2291's Return on Equity (11.5%) is considered low.